{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:15:23Z","timestamp":1789996523554,"version":"4.0.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["KWF 2012-5711"],"award-info":[{"award-number":["KWF 2012-5711"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["KWF 2013-6269"],"award-info":[{"award-number":["KWF 2013-6269"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["KWF 2015-7925"],"award-info":[{"award-number":["KWF 2015-7925"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["KWF 2012-5711"],"award-info":[{"award-number":["KWF 2012-5711"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["KWF 2013-6269"],"award-info":[{"award-number":["KWF 2013-6269"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["KWF 2015-7925"],"award-info":[{"award-number":["KWF 2015-7925"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-55614-y","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T01:11:03Z","timestamp":1735866663000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Integrating genetic subtypes with PET scan monitoring to predict outcome in diffuse large B-cell lymphoma"],"prefix":"10.1038","volume":"16","author":[{"given":"Mat\u00edas S.","family":"Mendeville","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2536-7864","authenticated-orcid":false,"given":"Jurriaan","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Tjitske","family":"Los-de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9543-4084","authenticated-orcid":false,"given":"Julia","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Nijland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaretha G. M.","family":"Roemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phylicia","family":"Stathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie J.","family":"Hijmering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reno","family":"Bladergroen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8395-2598","authenticated-orcid":false,"given":"Diego A.","family":"Pelaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9239-1050","authenticated-orcid":false,"given":"Arjan","family":"Diepstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne J.","family":"Eertink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coreline N.","family":"Burggraaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2995-2131","authenticated-orcid":false,"given":"Yongsoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieternella J.","family":"Lugtenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8894-2638","authenticated-orcid":false,"given":"Anke","family":"van den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1100-3819","authenticated-orcid":false,"given":"Alexandar","family":"Tzankov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Dirnhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"D\u00fchrsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2230-3873","authenticated-orcid":false,"given":"Andreas","family":"H\u00fcttmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7208-4117","authenticated-orcid":false,"given":"Wolfram","family":"Klapper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9e M.","family":"Zijlstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9479-3010","authenticated-orcid":false,"given":"Bauke","family":"Ylstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9725-4060","authenticated-orcid":false,"given":"Daphne","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,2]]},"reference":[{"key":"55614_CR1","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJM199309303291402","volume":"329","author":"MA Shipp","year":"1993","unstructured":"Shipp, M. A. & Harrington, D. P. A predictive model for aggressive non-Hodgkin\u2019s lymphoma. N. Engl. J. Med. 329, 987\u2013994 (1993).","journal-title":"N. Engl. J. Med."},{"key":"55614_CR2","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1182\/blood.2022015851","volume":"140","author":"E Campo","year":"2022","unstructured":"Campo, E. et al. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee. Blood 140, 1229\u20131253 (2022).","journal-title":"Blood"},{"key":"55614_CR3","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio, R. et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia 36, 1720\u20131748 (2022).","journal-title":"Leukemia"},{"key":"55614_CR4","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1200\/JCO.2016.69.0198","volume":"35","author":"GW Van Imhoff","year":"2017","unstructured":"Van Imhoff, G. W. et al. Ofatumumab versus rituximab salvage chemoimmunotherapy in relapsed or refractory diffuse large B-cell lymphoma: The ORCHARRD study. J. Clin. Oncol. 35, 544\u2013551 (2017).","journal-title":"J. Clin. Oncol."},{"key":"55614_CR5","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/bjh.15412","volume":"182","author":"C Gisselbrecht","year":"2018","unstructured":"Gisselbrecht, C. & Van Den Neste, E. How I manage patients with relapsed\/refractory diffuse large B cell lymphoma. Br. J. Haematol. 182, 633\u2013643 (2018).","journal-title":"Br. J. Haematol."},{"key":"55614_CR6","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/ajh.25460","volume":"94","author":"Y Liu","year":"2019","unstructured":"Liu, Y. & Barta, S. K. Diffuse large B-cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment. Am. J. Hematol. 94, 604\u2013616 (2019).","journal-title":"Am. J. Hematol."},{"key":"55614_CR7","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1056\/NEJMoa2115304","volume":"386","author":"H Tilly","year":"2022","unstructured":"Tilly, H. et al. Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma. N. Engl. J. Med. 386, 351\u2013363 (2022).","journal-title":"N. Engl. J. Med."},{"key":"55614_CR8","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/S1470-2045(18)30935-5","volume":"20","author":"A Davies","year":"2019","unstructured":"Davies, A. et al. Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial. Lancet Oncol. 20, 649\u2013662 (2019).","journal-title":"Lancet Oncol."},{"key":"55614_CR9","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1200\/JCO.18.02403","volume":"37","author":"A Younes","year":"2019","unstructured":"Younes, A. et al. Randomized phase III trial of ibrutinib and rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in non\u2013germinal center B-cell diffuse large B-cell lymphoma. J. Clin. Oncol. 37, 1285\u20131295 (2019).","journal-title":"J. Clin. Oncol."},{"key":"55614_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/hon.5_2629","volume":"37","author":"U Vitolo","year":"2019","unstructured":"Vitolo, U. et al. ROBUST: First report of phase III randomized study of lenalidomide\/R-CHOP (R 2 -CHOP) vs placebo\/R-CHOP in previously untreated ABC-type diffuse large B-cell lymphoma. Hematol. Oncol. 37, 36\u201337 (2019).","journal-title":"Hematol. Oncol."},{"key":"55614_CR11","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1200\/JCO.23.00033","volume":"41","author":"AJ Davies","year":"2023","unstructured":"Davies, A. J. et al. Differential Efficacy From the Addition of Bortezomib to R-CHOP in Diffuse Large B-Cell Lymphoma According to the Molecular Subgroup in the REMoDL-B Study With a 5-Year Follow-Up. J. Clin. Oncol.\u00a041, 2718\u20132723 (2023).","journal-title":"J. Clin. Oncol."},{"key":"55614_CR12","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","volume":"24","author":"B Chapuy","year":"2018","unstructured":"Chapuy, B. et al. Molecular subtypes of Diffuse Large B-cell Lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat. Med. 24, 679\u2013690 (2018).","journal-title":"Nat. Med."},{"key":"55614_CR13","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.cell.2017.09.027","volume":"171","author":"A Reddy","year":"2017","unstructured":"Reddy, A. et al. Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma. Cell 171, 481\u2013494 (2017).","journal-title":"Cell"},{"key":"55614_CR14","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","volume":"378","author":"R Schmitz","year":"2018","unstructured":"Schmitz, R. et al. Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma. N. Engl. J. Med. 378, 1396\u20131407 (2018).","journal-title":"N. Engl. J. Med."},{"key":"55614_CR15","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1182\/blood.2019003535","volume":"135","author":"SE Lacy","year":"2020","unstructured":"Lacy, S. E. et al. Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report. Blood 135, 1759\u20131771 (2020).","journal-title":"Blood"},{"key":"55614_CR16","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","volume":"37","author":"GW Wright","year":"2020","unstructured":"Wright, G. W. et al. A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications. Cancer Cell 37, 551\u2013568.e14 (2020).","journal-title":"Cancer Cell"},{"key":"55614_CR17","doi-asserted-by":"publisher","first-page":"970063","DOI":"10.3389\/fonc.2022.970063","volume":"12","author":"M Mendeville","year":"2022","unstructured":"Mendeville, M. et al. The path towards consensus genome classification of diffuse large B-cell lymphoma for use in clinical practice. Front. Oncol. 12, 970063 (2022).","journal-title":"Front. Oncol."},{"key":"55614_CR18","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1056\/NEJMra2027612","volume":"384","author":"LH Sehn","year":"2021","unstructured":"Sehn, L. H., Salles, G., LH, S. & G, S. Diffuse Large B-Cell Lymphoma. N. Engl. J. Med. 384, 842\u2013858 (2021).","journal-title":"N. Engl. J. Med."},{"key":"55614_CR19","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1038\/s41375-022-01670-6","volume":"36","author":"M Mendeville","year":"2022","unstructured":"Mendeville, M. et al. A bioinformatics perspective on molecular classification of diffuse large B-cell lymphoma. Leukemia 36, 2177\u20132179 (2022).","journal-title":"Leukemia"},{"key":"55614_CR20","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.ccell.2021.10.006","volume":"39","author":"WH Wilson","year":"2021","unstructured":"Wilson, W. H. et al. Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL. Cancer Cell 39, 1643\u20131653.e3 (2021).","journal-title":"Cancer Cell"},{"key":"55614_CR21","doi-asserted-by":"crossref","unstructured":"Nastoupil L. J. & Bartlett N. L. Navigating the Evolving Treatment Landscape of Diffuse Large B-Cell Lymphoma. J. Clin. Oncol. 41, 903\u2013913 (2023).","DOI":"10.1200\/JCO.22.01848"},{"key":"55614_CR22","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/bjh.17132","volume":"192","author":"HFP Runge","year":"2021","unstructured":"Runge, H. F. P. et al. Application of the LymphGen classification tool to 928 clinically and genetically-characterised cases of diffuse large B cell lymphoma (DLBCL). Br. J. Haematol. 192, 216\u2013220 (2021).","journal-title":"Br. J. Haematol."},{"key":"55614_CR23","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.3324\/haematol.2019.227892","volume":"105","author":"CR Bolen","year":"2019","unstructured":"Bolen, C. R. et al. Prognostic impact of somatic mutations in diffuse large B-cell lymphoma and relationship to cell-of-origin: data from the phase III GOYA study. Haematologica 105, 2298\u20132307 (2019).","journal-title":"Haematologica"},{"key":"55614_CR24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ebiom.2019.09.034","volume":"48","author":"S Dubois","year":"2019","unstructured":"Dubois, S. et al. Refining diffuse large B-cell lymphoma subgroups using integrated analysis of molecular profiles. EBioMedicine 48, 58\u201369 (2019).","journal-title":"EBioMedicine"},{"key":"55614_CR25","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1200\/JCO.21.02063","volume":"40","author":"NG Mikhaeel","year":"2022","unstructured":"Mikhaeel, N. G. et al. Proposed New Dynamic Prognostic Index for Diffuse Large B-Cell Lymphoma: International Metabolic Prognostic Index. J. Clin. Oncol. 40, 2352\u20132360 (2022).","journal-title":"J. Clin. Oncol."},{"key":"55614_CR26","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/bloodadvances.2021004467","volume":"5","author":"JJ Eertink","year":"2021","unstructured":"Eertink, J. J. et al. Optimal timing and criteria of interim PET in DLBCL: a comparative study of 1692 patients. Blood Adv. 5, 2375\u20132384 (2021).","journal-title":"Blood Adv."},{"key":"55614_CR27","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s11899-016-0318-1","volume":"11","author":"SF Barrington","year":"2016","unstructured":"Barrington, S. F. & Mikhaeel, N. G. PET Scans for Staging and Restaging in Diffuse Large B-Cell and Follicular Lymphomas. Curr. Hematol. Malig. Rep. 11, 185\u2013195 (2016).","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"55614_CR28","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1182\/blood.2022016095","volume":"140","author":"K Dreval","year":"2022","unstructured":"Dreval, K., Boutros, P. C. & Morin, R. D. Minimal information for reporting a genomics experiment. Blood 140, 2549\u20132555 (2022).","journal-title":"Blood"},{"key":"55614_CR29","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1158\/2159-8290.CD-20-0174","volume":"10","author":"D Ennishi","year":"2020","unstructured":"Ennishi, D., Hsi, E. D., Steidl, C. & Scott, D. W. Toward a New Molecular Taxonomy of Diffuse Large B-cell Lymphoma. Cancer Discov. 10, 1267\u20131281 (2020).","journal-title":"Cancer Discov."},{"key":"55614_CR30","doi-asserted-by":"publisher","first-page":"3679","DOI":"10.1182\/blood-2015-03-635169","volume":"125","author":"DM Kurtz","year":"2015","unstructured":"Kurtz, D. M. et al. Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing. Blood 125, 3679\u20133687 (2015).","journal-title":"Blood"},{"key":"55614_CR31","first-page":"51","volume":"36","author":"MA Spinner","year":"2022","unstructured":"Spinner, M. A. & Advani, R. H. Current Frontline Treatment of Diffuse Large B-Cell Lymphoma. Oncology 36, 51\u201358 (2022).","journal-title":"Oncology"},{"key":"55614_CR32","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.1200\/JCO.19.03418","volume":"38","author":"PJ Lugtenburg","year":"2020","unstructured":"Lugtenburg, P. J. et al. Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma: A Randomized Phase III Trial of the HOVON and the Nordic Lymphoma Group (HOVON-84). J. Clin. Oncol. 38, 3377\u20133387 (2020).","journal-title":"J. Clin. Oncol."},{"key":"55614_CR33","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1200\/JCO.2017.76.8093","volume":"36","author":"U D\u00fchrsen","year":"2018","unstructured":"D\u00fchrsen, U. et al. Positron emission tomography-guided therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A multicenter, randomized phase III trial. J. Clin. Oncol. 36, 2024\u20132034 (2018).","journal-title":"J. Clin. Oncol."},{"key":"55614_CR34","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13045-015-0168-7","volume":"8","author":"A Tzankov","year":"2015","unstructured":"Tzankov, A. et al. Multiparameter analysis of homogeneously R-CHOP-treated diffuse large B cell lymphomas identifies CD5 and FOXP1 as relevant prognostic biomarkers: report of the prospective SAKK 38\/07 study. J. Hematol. Oncol. 8, 70 (2015).","journal-title":"J. Hematol. Oncol."},{"key":"55614_CR35","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1200\/JCO.2013.53.5229","volume":"32","author":"SF Barrington","year":"2014","unstructured":"Barrington, S. F. et al. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J. Clin. Oncol. 32, 3048\u20133058 (2014).","journal-title":"J. Clin. Oncol."},{"key":"55614_CR36","unstructured":"Swerdlow S. H., et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. WHO Ser. Histol. Genet. typing Hum. tumours (2017)."},{"key":"55614_CR37","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1101\/gr.175141.114","volume":"24","author":"I Scheinin","year":"2014","unstructured":"Scheinin, I. et al. DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly. Genome Res. 24, 2022\u20132032 (2014).","journal-title":"Genome Res."},{"key":"55614_CR38","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1182\/blood-2017-12-822171","volume":"133","author":"Mendeville","year":"2019","unstructured":"Mendeville et al. Aggressive genomic features in clinically indolent primary HHV8-negative effusion-based lymphoma. Blood 133, 377\u2013380 (2019).","journal-title":"Blood"},{"key":"55614_CR39","doi-asserted-by":"publisher","first-page":"D980","DOI":"10.1093\/nar\/gkab1059","volume":"50","author":"Freeberg","year":"2022","unstructured":"Freeberg et al. The European Genome-phenome Archive in 2021. Nucleic Acids Res 50, D980\u2013D987 (2022).","journal-title":"Nucleic Acids Res"},{"key":"55614_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12308-015-0259-y","volume":"9","author":"M van den Brand","year":"2016","unstructured":"van den Brand, M. et al. A subset of low-grade B cell lymphomas with a follicular growth pattern but without a BCL2 translocation shows features suggestive of nodal marginal zone lymphoma. J. Hematop. 9, 3\u20138 (2016).","journal-title":"J. Hematop."},{"key":"55614_CR41","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3816\/CLML.2011.n.003","volume":"11","author":"N Rayman","year":"2011","unstructured":"Rayman, N. et al. Prognostic relevance of immunohistochemical subclassification of diffuse large B-cell lymphoma in two prospective phase III clinical trials. Clin. Lymphoma, Myeloma Leuk. 11, 23\u201332 (2011).","journal-title":"Clin. Lymphoma, Myeloma Leuk."},{"key":"55614_CR42","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","volume":"103","author":"CP Hans","year":"2004","unstructured":"Hans, C. P. et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103, 275\u2013282 (2004).","journal-title":"Blood"},{"key":"55614_CR43","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/bty1055","volume":"35","author":"JB Poell","year":"2019","unstructured":"Poell, J. B. et al. ACE: absolute copy number estimation from low-coverage whole-genome sequencing data. Bioinformatics 35, 2847\u20132849 (2019).","journal-title":"Bioinformatics"},{"key":"55614_CR44","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13045-017-0438-7","volume":"10","author":"D Juskevicius","year":"2017","unstructured":"Juskevicius, D. et al. Mutations of CREBBP and SOCS1 are independent prognostic factors in diffuse large B cell lymphoma: mutational analysis of the SAKK 38\/07 prospective clinical trial cohort. J. Hematol. Oncol. 10, 70 (2017).","journal-title":"J. Hematol. Oncol."},{"key":"55614_CR45","doi-asserted-by":"publisher","first-page":"11189","DOI":"10.1093\/nar\/gks918","volume":"40","author":"A Wilm","year":"2012","unstructured":"Wilm, A. et al. LoFreq: A sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets. Nucleic Acids Res. 40, 11189\u201311201 (2012).","journal-title":"Nucleic Acids Res"},{"key":"55614_CR46","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1101\/gr.129684.111","volume":"22","author":"DC Koboldt","year":"2012","unstructured":"Koboldt, D. C. et al. VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 22, 568\u2013576 (2012).","journal-title":"Genome Res"},{"key":"55614_CR47","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1093\/nar\/gku1211","volume":"43","author":"RP Abo","year":"2015","unstructured":"Abo, R. P. et al. BreaKmer: detection of structural variation in targeted massively parallel sequencing data using kmers. Nucleic Acids Res 43, e19 (2015).","journal-title":"Nucleic Acids Res"},{"key":"55614_CR48","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nmeth.4084","volume":"14","author":"Z Chong","year":"2016","unstructured":"Chong, Z. et al. NovoBreak: Local assembly for breakpoint detection in cancer genomes. Nat. Methods 14, 65\u201367 (2016).","journal-title":"Nat. Methods"},{"key":"55614_CR49","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1101\/gr.222109.117","volume":"27","author":"DL Cameron","year":"2017","unstructured":"Cameron, D. L. et al. GRIDSS: Sensitive and specific genomic rearrangement detection using positional de Bruijn graph assembly. Genome Res 27, 2050\u20132060 (2017).","journal-title":"Genome Res"},{"key":"55614_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pcbi.1004572","volume":"11","author":"ZN Kronenberg","year":"2015","unstructured":"Kronenberg, Z. N. et al. Wham: Identifying Structural Variants of Biological Consequence. PLoS Comput. Biol. 11, 1\u201319 (2015).","journal-title":"PLoS Comput. Biol."},{"key":"55614_CR51","doi-asserted-by":"crossref","unstructured":"Allahyar A. et al. Robust detection of translocations in lymphoma sequencing. Nat. Commun. 12, 3361 (2021).","DOI":"10.1038\/s41467-021-23695-8"},{"key":"55614_CR52","doi-asserted-by":"publisher","first-page":"4164","DOI":"10.1073\/pnas.0308531101","volume":"101","author":"JP Brunet","year":"2004","unstructured":"Brunet, J. P., Tamayo, P., Golub, T. R. & Mesirov, J. P. Metagenes and molecular pattern discovery using matrix factorization. Proc. Natl Acad. Sci. Usa. 101, 4164\u20134169 (2004).","journal-title":"Proc. Natl Acad. Sci. Usa."},{"key":"55614_CR53","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1023\/A:1023949509487","volume":"52","author":"S Monti","year":"2003","unstructured":"Monti, S., Tamayo, P., Mesirov, J. & Golub, T. Consensus clustering: A resampling-based method for class discovery and visualization of gene expression microarray data. Mach. Learn. 52, 91\u2013118 (2003).","journal-title":"Mach. Learn."},{"key":"55614_CR54","doi-asserted-by":"publisher","unstructured":"Tumor Genome Analysis Core, Integrating Genetic Subtypes with PET Scan Monitoring to Predict Outcome in Diffuse Large B-Cell Lymphoma, qDNAseq-snakemake. https:\/\/doi.org\/10.5281\/zenodo.13969159 (2024).","DOI":"10.5281\/zenodo.13969159"},{"key":"55614_CR55","doi-asserted-by":"publisher","unstructured":"Mendeville M. Integrating Genetic Subtypes with PET Scan Monitoring to Predict Outcome in Diffuse Large B-Cell Lymphoma, tumor-only-snakemake. https:\/\/doi.org\/10.5281\/zenodo.13969165 (2024).","DOI":"10.5281\/zenodo.13969165"},{"key":"55614_CR56","doi-asserted-by":"publisher","unstructured":"Los-de Vries T. Integrating Genetic Subtypes with PET Scan Monitoring to Predict Outcome in Diffuse Large B-Cell Lymphoma, translocation-snakemake. https:\/\/doi.org\/10.5281\/zenodo.13969169 (2024).","DOI":"10.5281\/zenodo.13969169"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-55614-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-55614-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-55614-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T02:05:09Z","timestamp":1735869909000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-55614-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,2]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["55614"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-55614-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,2]]},"assertion":[{"value":"22 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"109"}}